"Three-nothing" culture system of NK cells in Hanls laboratory

NKThe clinical use of cell therapy includes collection, activation, expansion and application of anti-tumor clinical translation. NK cell adoptive immunotherapy (ACT) is one of the methods of cell biological therapy. One method is to return the NK cells induced and cultured in vitro to the patient, a large number ofNKCells circulate throughout the body with the blood3000Next to4000 times, kill cancer cells, aging cells, diseased cells, bacteria and viruses in the body, so as to achieve anti-cancer and anti-cancer effects. Cancer, anti-virus, anti-aging, boost immunity, less or no disease.

In conventional laboratories, the addition of feeder cells in the culture system requires additional purification steps and residue detection, which not only brings about production costs It also increases the risk of clinical use. Therefore, at present, the in vitro expansion system of NK cells derived from peripheral bloodwill be used for No prepurification, no feeder cells, no serumThe development of the culture system. Hales Lab"Three-None" culture system, can obtain thousands of times of NK cell expansion in 2 weeks, the number is > 5×10⁹(5 billion), >95% pure product. Its number is 3 to 5 times more than that of industry laboratories.

Hales LabNK cell technology includes:

●T-NK cells, cancer treatment,hepatitis B virus(HBV) Infection, human papilloma (HPV) virus infection and other diseases;

●B-NK cells for the treatment of type 2 diabetes;

●D-NK cells for the treatment of rheumatoid arthritis, lupus, psoriasis and other autoimmune diseases;

●C-NK cells, remove senescent cells and prolong healthy lifespan.